Skip to content

Clinical trials

Observational Osteoporosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Phase: Observational Clear all

452 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20014
20022
20038
20049
200511
200617
200714
200819
200914
201017
201112
201225
201326
201416
201516
201618
201717
201815
201912
202022
202119
202218
202339
202425
202517
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed257
Unknown status96
Recruiting41
Not yet recruiting16
Active, not recruiting13
Terminated13
Withdrawn8
Enrolling by invitation7
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital14
Uskudar State Hospital11
Beylikduzu State Hospital5
Tomidahama Hospital5
Assistance Publique - Hôpitaux de Paris4
Central Hospital, Nancy, France4
Centre Hospitalier Universitaire de Nice4
GlaxoSmithKline4
Istituto Ortopedico Rizzoli4
Peking University Third Hospital4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis452
Bone Diseases, Metabolic51
Fractures, Bone47
Diabetes Mellitus24
Sarcopenia23
Osteoporosis, Postmenopausal21
Osteoporotic Fractures20
Hip Fractures19
Obesity17
Cardiovascular Diseases16

Trials

Showing 26 to 50 of 452. Each trial links to its page on Pharma Observatory.

352 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.